BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11394329)

  • 1. Racial variation in prostate specific antigen in a large cohort of men without prostate cancer.
    Eastham JA; Sartor O; Richey W; Moparty B; Sullivan J
    J La State Med Soc; 2001 Apr; 153(4):184-9. PubMed ID: 11394329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
    Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
    J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen test use and digital rectal examinations among African-American men, 2002-2006.
    Ross LE; Meade SA; Powe BD; Howard DL
    J Natl Black Nurses Assoc; 2009 Jul; 20(1):52-8. PubMed ID: 19691184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
    Fowler JE; Bigler SA; Farabaugh PB
    Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa.
    Heyns CF; Mathee S; Isaacs A; Kharwa A; De Beer PM; Pretorius MA
    BJU Int; 2003 Jun; 91(9):785-8. PubMed ID: 12780832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer detection in Black and White men with abnormal digital rectal examination and prostate specific antigen less then 4 ng./ml.
    Fowler JE JR; Bigler SA; Farabaugh PB; Wilson SS
    J Urol; 2000 Dec; 164(6):1961-3. PubMed ID: 11061891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer.
    Eastham JA; May RA; Whatley T; Crow A; Venable DD; Sartor O
    J Natl Cancer Inst; 1998 May; 90(10):756-60. PubMed ID: 9605645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
    Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
    J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.
    Fowler JE; Bigler SA; Kilambi NK; Land SA
    Urology; 1999 Jun; 53(6):1175-8. PubMed ID: 10367848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network.
    Weinrich SP
    Cancer; 2006 Feb; 106(4):796-803. PubMed ID: 16411222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.
    Abdalla I; Ray P; Vaida F; Vijayakumar S
    Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men.
    Lam JS; Cheung YK; Benson MC; Goluboff ET
    J Urol; 2003 Aug; 170(2 Pt 1):451-6. PubMed ID: 12853797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statewide analysis of serum prostate specific antigen levels in Louisiana men without prostate cancer.
    Kyle C; Ewing T; Wu XC; Mercante D; Lifsey D; Meunier C; Jefferson L; Sartor O; Rayford W
    J La State Med Soc; 2004; 156(6):319-23. PubMed ID: 15688673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen concentration in young men: new estimates and review of the literature.
    Sutcliffe S; Pakpahan R; Sokoll LJ; Elliott DJ; Nevin RL; Cersovsky SB; Walsh PC; Platz EA
    BJU Int; 2012 Dec; 110(11):1627-35. PubMed ID: 22502603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race.
    Fowler JE; Bigler SA; Lynch C; Wilson SS; Farabaugh PB
    Cancer; 2001 Apr; 91(7):1291-6. PubMed ID: 11283929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
    Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
    Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
    Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
    J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.